The UK's most complete GLP-1 guide
Every Question Answered. Every Side Effect Explained.
- How GLP-1 medications work
- Mounjaro vs Wegovy compared
- Injection instructions
- Side effects & solutions
- What to eat on treatment
- FAQs answered
Free tracker included with every download this week
Understanding Mounjaro Testimonials in the UK
Mounjaro testimonials from UK users can provide insight into real-world weight management experiences, but it's important to understand that individual results vary significantly. Tirzepatide (Mounjaro) is a prescription-only GLP-1 receptor agonist injection licensed in the UK for weight management in adults. While personal accounts can be helpful, your own experience will depend on your health profile, lifestyle, and how your body responds to the medication. This guide explains the NHS context for Mounjaro, eligibility criteria, and what evidence shows about expected outcomes.
10,000+ calculations today · NHS-aligned thresholds · 100% free
Calculate Your BMI Instantly
Enter your height and weight below. Supports both imperial (stone & lbs) and metric (kg). Results include NHS category, healthy weight range, and ethnicity adjustments.
What Is BMI and Why Does It Matter?
Body Mass Index (BMI) is the most widely used screening tool for assessing whether your weight falls within a healthy range. Used by the NHS, GPs, and weight management services across the UK, BMI provides a quick snapshot of your weight relative to your height. The formula is simple: your weight in kilograms divided by your height in metres squared (kg/m²).
While BMI isn't a perfect measure — it doesn't account for muscle mass, bone density, or fat distribution — it remains the standard first step in identifying potential weight-related health risks including type 2 diabetes, cardiovascular disease, high blood pressure, and certain cancers.
The NHS also recommends adjusted thresholds for people of South Asian, Chinese, or Black African heritage — a BMI of 23 or above is classified as overweight, and 27.5 as obese. Our calculator includes this adjustment as a one-click toggle.
What the Evidence Shows About Mounjaro
Rather than relying solely on testimonials, the strongest evidence for Mounjaro comes from the SURMOUNT clinical trials, which tested tirzepatide in UK and international populations. In SURMOUNT-1, participants taking the maximum 15 mg dose lost an average of approximately 20.9% of their body weight over 72 weeks, alongside a reduced-calorie diet and increased physical activity. The 10 mg dose showed average weight loss of around 19.5%. These are averages — individual results ranged from 5% to over clinically studied weight loss.
Common experiences reported by trial participants included initial nausea (usually improving after the first few weeks), improved appetite control, and gradual weight loss. However, not everyone experiences the same side effects or weight loss outcomes. Your GP or prescriber can discuss what the evidence suggests for your specific situation and help you understand realistic expectations for your individual health.
Clinically BackedWeight Loss
No appointments. No waiting rooms. Just care — from a UK-regulated online pharmacy.
How It Works
Three simple steps to understand your weight and take action.
Enter your height and weight in our free calculator. Get your BMI, NHS category, healthy weight range, and ethnicity-adjusted thresholds instantly.
If your BMI suggests you're overweight or obese, explore our GLP-1 calculators to project potential weight loss on Mounjaro or Wegovy.
Use our progress tracker to log your weight weekly, visualise your journey with charts, and stay motivated — all stored privately in your browser.
Free Weight Loss Tools & Guides
Everything you need to understand your weight, explore medication options, and track your progress — completely free.
Accessing Mounjaro Through NHS vs Private Routes
NHS access to Mounjaro is available through tier 3 specialist weight management services following NICE approval. This means you'll typically need a GP referral to a regional specialist weight management team, who will assess your eligibility based on your BMI and health conditions. NHS access is free but varies significantly by region — some areas have substantial waiting lists. When prescribed through the NHS, your KwikPen injections are dispensed via your local NHS pharmacy.
Private access involves an online consultation with a UK-licensed prescriber who will assess your suitability. If approved, you'll receive a prescription dispensed by a GPhC-registered pharmacy. Private routes are faster but involve personal cost (typically £150–£300+ per month depending on dose). Both routes require a clinical assessment — Mounjaro is never available without a prescription. Use our free GLP-1 weight loss calculator to explore potential outcomes at different doses.
- Dual GIP/GLP-1 receptor agonist
- Up to 22.5% body weight loss (SURMOUNT-1)
- Weekly injection, dose escalation over 20+ weeks
- Available via private prescription in the UK
- Doses: 2.5mg → 5mg → 7.5mg → 10mg → 12.5mg → 15mg
- GLP-1 receptor agonist
- Up to 15–17% body weight loss (STEP trials)
- Weekly injection, 5-step dose escalation
- NHS & private prescription available
- Doses: 0.25mg → 0.5mg → 1mg → 1.7mg → 2.4mg
Mounjaro vs Wegovy: Head-to-Head
A side-by-side comparison of the two most popular GLP-1 weight loss medications available in the UK.
| Feature | Mounjaro | Wegovy |
|---|---|---|
| Drug class | Dual GIP/GLP-1 agonist | GLP-1 agonist |
| Active ingredient | Tirzepatide | Semaglutide |
| Avg. weight loss | 15–22.5% | 12–17% |
| Key trial | SURMOUNT-1 (2022) | STEP 1 (2021) |
| Max dose | 15 mg weekly | 2.4 mg weekly |
| Escalation period | 20–32 weeks | 16–20 weeks |
| Administration | Weekly injection (pen) | Weekly injection (pen) |
| NHS availability | Private prescription only | NHS & private |
| Approx. private cost | £150–£250/month | £150–£300/month |
| Common side effects | Nausea, diarrhoea, constipation | Nausea, vomiting, diarrhoea |
Data sourced from SURMOUNT-1 and STEP 1 clinical trials. Costs are approximate and vary by provider. Always consult a prescriber.
Am I Eligible for Weight Loss Medication?
In the UK, eligibility for GLP-1 weight loss medications like Mounjaro and Wegovy is based on your BMI and overall health profile.
- BMI of 30 or above (obese)
- Age 18 or over
- No contraindicated conditions
- Committed to lifestyle changes
- BMI of 27 or above
- Plus type 2 diabetes
- Or high blood pressure
- Or obstructive sleep apnoea
Use our BMI calculator to check whether your BMI falls within the eligible range.
How We Built These Tools
Every calculator and guide on myweightcheck is built with accuracy and transparency in mind. Our BMI calculator uses the standard WHO formula with NHS-aligned category thresholds. Our GLP-1 projections are modelled on published clinical trial data from SURMOUNT and STEP studies.
All data stays on your device. We don't require sign-ups, and we don't store your health information on any server. Your progress tracker saves data locally in your browser using localStorage, so only you can see it.
We're based in the UK and our tools are designed specifically for UK users — supporting stone & lbs by default, referencing NHS guidelines, using NICE-approved medication data, and linking to GPhC-registered pharmacies.
Frequently Asked Questions
Common questions about BMI, weight loss medications, and our free UK tools.
Can I get Mounjaro on the NHS in the UK?
Yes, Mounjaro is approved by NICE for NHS use through tier 3 specialist weight management services. You'll need a GP referral and assessment showing a BMI of 30 or above (or 27+ with weight-related health conditions). Availability and waiting times vary by region. Your GP can tell you about services in your area.
What's the difference between reading testimonials and clinical trial data?
Testimonials reflect individual experiences but can't predict your outcome — they're subject to bias and selection effects. Clinical trials like SURMOUNT provide average results across hundreds of participants, showing what percentage of people experienced certain outcomes. Both have value, but trial data is more reliable for setting realistic expectations.
How does the Mounjaro KwikPen work, and is it hard to use?
The KwikPen is a pre-filled auto-injection device — you dial your dose and press the button to inject. Most users find it straightforward after training. Your healthcare provider will demonstrate proper technique. Each pen contains four weekly doses and requires refrigeration (2–8°C unopened, or room temperature for up to 30 days after first use).
How does Mounjaro compare to Wegovy for weight loss outcomes?
In trials, Mounjaro (tirzepatide) showed slightly higher average weight loss (~20.9% at 15 mg) than Wegovy (semaglutide, ~14.9% at 2.4 mg). However, individual results vary widely. Mounjaro uses dual GIP/GLP-1 receptor agonism versus Wegovy's single GLP-1 mechanism. Your prescriber can discuss which suits your health profile.
What happens if I experience side effects like nausea when starting Mounjaro?
Nausea is very common initially but typically improves within the first few weeks as your body adjusts. Your prescriber may recommend dietary adjustments (smaller, frequent meals; avoiding fatty foods). If side effects persist or worsen, contact your healthcare provider — dose adjustments or alternative options may help.
Ready to take control of your weight loss journey?
Start with a free BMI check, explore your GLP-1 options, or begin tracking your progress today. No sign-up. No cost. Just results.